Thomas Nittoli | Director
Regeneron Pharmaceuticals

Thomas Nittoli, Director, Regeneron Pharmaceuticals

Tom Nittoli has over 20 years of experience in the pharmaceutical industry and is currently Director of R&D Chemistry.  Dr. Nittoli joined Regeneron in 2010 to advance conjugated antibodies and proteins from discovery to development.  Since joining Regeneron, he has developed a variety of small molecules for protein conjugation, lead diverse teams of discovery ADC scientists, and lead cGMP synthesis and conjugation campaigns. Prior to Regeneron, Dr. Nittoli held positions at Pfizer, Wyeth, and CIBA-Giegy.  He holds a PhD from the department of chemistry SUNY Stony Brook and was a post-doctoral fellow at the University of Pennsylvania.

Appearances:



European Antibody Congress 2018, Day 1 @ 14:50

Development of potent and efficacious with payloads that target tubulin

  • Payload and linker development
  • In vitro screening
  • In vivo efficacy
last published: 17/Jul/18 15:35 GMT
last published: 17/Jul/18 15:35 GMT

back to speakers

Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates